What's in Actavis Mid-Atlantic LLC's pipeline?

Actavis Mid-Atlantic LLC has 3 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Actavis Mid-Atlantic LLC's portfolio?

Top competitors by shared drug class: Active Biotech AB, Air Force Military Medical University, China, Astellas Pharma Inc, Bayer, Beijing Children's Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/actavis-mid-atlantic-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Actavis Mid-Atlantic LLC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Actavis Mid-Atlantic LLC pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ZIANA®	ZIANA®	marketed			Other
imiquimod cream, 3.75%	imiquimod cream, 3.75%	phase 3	Immunomodulator	TLR7, TLR8	Dermatology

Therapeutic area mix

Dermatology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Active Biotech AB · 1 shared drug class
Air Force Military Medical University, China · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
Bayer · 1 shared drug class
Beijing Children's Hospital · 1 shared drug class
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 1 shared drug class
Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri · 1 shared drug class
ALK-Abelló A/S · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Actavis Mid-Atlantic LLC:

Cite this brief

Drug Landscape (2026). Actavis Mid-Atlantic LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/actavis-mid-atlantic-llc. Accessed 2026-06-10.